Robert L. Feldman, MD

Bailout Use of Platelet Glycoprotein IIb/IIIa Inhibition During Coronary Stent Implantation: Observations from the ESPRIT Trial

08/01/2008

James E. Tcheng , MD;

Michael M. Kitt , MD;

David J. Cohen , MD, MPH, MSc;

Robert J. Chisholm , MD, FRCPC;

Henry K. Lui , MD;

Robert L. Feldman , MD;

Robert Green , MD;

Anne S. Hellkamp , PhD;

Warren J. Cantor , MD;

J. Conor O'Shea , MD;

Mina Madan , MD, MPH;

Potent inhibition of platelet aggregation during percutaneous coronary intervention (PCI) using intravenous antagonists of the platelet glycoprotein (GP) IIb/IIIa receptor results in a significant and sustained reduction in the occurrence of...

Potent inhibition of platelet...

08/01/2008

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8 ⁠–⁠ November 10

November 8

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Robert L. Feldman, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products